120 likes | 228 Views
Global Cardiovascular drug Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023
E N D
GLOBAL CARDIOVASCULAR DRUG MARKET RESEARCH AND FORECAST 2018-2023 Orion Market Research
DEFINITION Cardiovascular drugs are used to treat a range of heart conditions, such as coronary artery disease, arrhythmia and hypertension. The cardiovascular agents include beta blockers, calcium channel blockers and antihyperlipidemic.
MARKET MOTIVATORS • Increasing environmental pollution, excessive alcohol consumption & smoking. • Changing lifestyle & shifts in work hours. • Technological advancement in healthcare. • Increasing healthcare expenditure in developing nation.
MARKET RESTRAINTS • High medication cost. • Strict governmental regulation for drug approval.
MARKET OPPORTUNITIES • Adoption of genetic engineering for diagnosis procedure. • Increase in r&d spending by pharmaceutical companies for drug discovery.
MARKET SEGMENTATION • BY DRUG TYPE • Anti-clotting agents • Antihyperlipidemic • Beta blockers • Calcium channel blockers • Diuretics • Renin-angiotensin system blockers • Other
MARKET SEGMENTATION • BY DISEASE • Arrhythmia • Coronary artery disease • Hyperlipidemia • Hypertension • Peripheral artery disease
MARKET PLAYERS • Abbott Laboratories, Inc. • Bayer AG • GlaxoSmithKline PLC • Johnson & Johnson, Inc. • Pfizer, Inc. • To Be Continued……
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com https://www.omrglobal.com/industry-reports/cvd-cardiovascular-drug-market/